Latest Breaking News On - Chinwe ukomadu - Page 1 : comparemela.com

Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia

Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Japan
United-states
Chinwe-ukomadu
Takeda-pharmaceutical-company-limited
Exchange-commission
Drug-administration
Inflammation-therapeutic-area-unit
Orphan-drug-designation
Fast-track
Fiscal-year
Annual-report

Takeda: Mezagitamab Phase 2 Trial Shows Positive Results In Primary Immune Thrombocytopenia

Takeda Pharmaceutical Co. Ltd. (TAK, TKPHF.PK) announced Wednesday positive topline results from a Phase 2 trial of mezagitamab (TAK-079) in patients with persistent or chronic primary immune thrombocytopenia or ITP.

Chinwe-ukomadu
More-such-health-news
Takeda-pharmaceutical-co
Drug-administration
Takeda-pharmaceutical
Orphan-drug-designation
Fast-track
Inflammation-therapeutic-area-unit

Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab TAK079 a Potential BestinClass AntiCD38 Monoclonal Antibody for Primary Immune Thrombocytopenia

TakedaTSE4502NYSETAK today announced positive topline results from a Phase 2 randomized doubleblind placebocontrolled study evaluating the safety tolerability and efficacy of mezagitamab TAK079 in patients with persistent or chronic primary immune thrombocytopenia ITP.

United-states
Osaka
Japan
Japanese
Chinwe-ukomadu
Yuko-yoneyama
Rodeghierof-international-journal-of-hematology
Takeda-pharmaceutical-company-limited
Exchange-commission
Development-in-fiscal-year
Drug-administration
Efficacy-results

Darvadstrocel Misses as Treatment for Complex Perianal Fistulas in Crohn Disease

Topline data was announced from a phase 3 study evaluating darvadstrocel for the treatment of complex perianal fistulas in adults with Crohn disease.

Chinwe-ukomadu
Therapeutic-area-unit

Takeda's stem cell Crohn's med Alofisel flunks phase 3 trial

Takeda's stem cell Crohn's med Alofisel flunks phase 3 trial
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Japan
Chinwe-ukomadu
European-union